Abstract

Chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) significantly Open Access n a impact patient quality of life and healthcare systems worldwide. Traditional pharmacotherapy often falls short in managing severe cases, leading to the exploration of biologics as a novel treatment avenue. Biologics, targeting a r y R e i l t a t i o specific inflammatory pathways and immune responses, have emerged as effective therapies for patients with asthma and COPD. This article reviews the utilization of biologics in the management of asthma and COPD, discussing their mechanisms, clinical efficacy, safety profiles, and future directions in treatment strategies.